• A40926: Dalbavancin Precursor for Gram-Positive Pathogen Res

  2026-08-06

  A40926 is a natural glycopeptide antibiotic and the direct precursor to dalbavancin, exhibiting potent and well-characterized bactericidal activity against Gram-positive bacteria and Neisseria gonorrhoeae. Its precise inhibition of bacterial cell wall synthesis and pathogen-specific MIC values make it indispensable for in vitro antibacterial assays and advanced antibiotic development.

• Bortezomib (PS-341): Applied Proteasome Inhibition in Cancer

  2026-08-06

  Bortezomib (PS-341) delivers robust, selective 20S proteasome inhibition, enabling high-sensitivity apoptosis and cell viability assays across cancer models. This article translates recent mechanistic insights and workflow advances into actionable protocols and troubleshooting strategies, spotlighting how Bortezomib from APExBIO empowers reproducible research.

• Doxorubicin Hydrochloride: Applied Workflows in Chemotherapy

  2026-08-05

  Harness the power of Doxorubicin hydrochloride in both cancer chemotherapy research and cardiotoxicity modeling. This article delivers actionable workflow enhancements, protocol optimization, and troubleshooting strategies to maximize experimental reproducibility and mechanistic insight.

• Pronase E Protease Mixture: Precision in Unbiased Protein Di

  2026-08-05

  Explore the advanced science and workflow impact of Pronase E, a potent protease mixture, for protein sample preparation and proteomic innovation. This cornerstone article offers unique mechanistic insights and practical guidance for researchers seeking superior results.

• Baricitinib (LY3009104): Applied Protocols for JAK1/2 Inhibi

  2026-08-04

  Baricitinib (LY3009104) offers high selectivity and reproducible inhibition of JAK1/2-driven cytokine pathways, making it indispensable for dissecting inflammatory signaling in disease models. This guide translates cutting-edge spatial proteomics findings into actionable protocols, troubleshooting, and workflow optimization for immune modulation research.

• Letrozole: Applied Workflows for Non-Steroidal Aromatase Inh

  2026-08-04

  Letrozole stands out as a potent, reversible non-steroidal aromatase inhibitor, enabling precision estrogen pathway modulation across breast cancer and neuroendocrine research. Discover protocol-ready parameters, troubleshooting tips, and comparative insights that translate bench evidence into robust experimental outcomes.

• Gepotidacin Applications: Protocols & Troubleshooting in Ant

  2026-08-03

  Gepotidacin (GSK2140944) revolutionizes antibacterial research by targeting DNA replication in resistant bacteria. This article delivers stepwise protocols, advanced troubleshooting, and evidence-backed optimization strategies to maximize experimental success with this next-generation topoisomerase inhibitor.

• Redefining Epithelial Repair Detection: Cy5 TSA in IBD Resea

  2026-08-03

  Explore how next-generation signal amplification technology, exemplified by the Cy5 TSA Fluorescence System Kit, is revolutionizing the detection of low-abundance targets and mechanistic studies of mucosal repair in inflammatory bowel disease. Integrating mechanistic insight from recent NET-ILC3-CCDC25 discoveries, this article guides translational researchers in leveraging advanced HRP-catalyzed tyramide deposition for high-sensitivity, quantitative mapping of immune and barrier processes in complex tissue microenvironments.

• CAY10499: Advanced Strategies for Lipid Metabolism and Immun

  2026-08-02

  Explore the unique biochemical properties and research applications of CAY10499, a potent inhibitor of human hormone sensitive lipase. This article delivers new insights on integrating CAY10499 into immunometabolic workflows and lipid metabolism assay design.

• IGF2BP1-m6A-TUBB4B Axis Regulates Hepatic Stellate Cell Acti

  2026-08-01

  This study uncovers how the m6A reader IGF2BP1 promotes hepatic stellate cell activation and liver fibrosis by stabilizing TUBB4B mRNA in an m6A-dependent manner. These findings provide new mechanistic insight into fibrogenesis and suggest the IGF2BP1/TUBB4B/FAK pathway as a potential therapeutic target.

• Bortezomib (PS-341): Proteasome Inhibitor Benchmarks & Limit

  2026-07-31

  Bortezomib (PS-341) is a reversible 20S proteasome inhibitor with robust, well-characterized efficacy in apoptosis and cancer research. Its validated potency in both in vitro and in vivo models, alongside precise solubility and storage guidelines, make it a gold standard for dissecting proteasome-regulated cellular processes in multiple myeloma and mantle cell lymphoma.

• Stress Fiber Anisotropy Regulates Force-Mode Chromatin Stret

  2026-07-31

  Wei et al. reveal that the orientation and integrity of stress fibers critically determine how living cells transduce different mechanical force modes into chromatin stretching and gene upregulation. Their use of 3D magnetic twisting cytometry and selective myosin II inhibition provides new mechanistic insight for cytoskeletal dynamics and gene regulation research.

• Sodium Ascorbate: Mechanistic Insights for Translational Onc

  2026-07-30

  This thought-leadership article explores the mechanistic foundation and translational promise of sodium ascorbate, a mineral salt of ascorbic acid, in cancer research. Focusing on its unique induction of intracellular ROS and consequent necrotic tumor cell death, the piece guides translational researchers through experimental models, clinical relevance, and evolving strategies for integrating sodium ascorbate into precision oncology workflows—especially in the context of tumor microenvironment modulation and immunotherapy biomarker discovery.

• Biotin (Vitamin B7): Molecular Gatekeeper in Metabolic and I

  2026-07-30

  Explore how Biotin (Vitamin B7) functions as a molecular bridge between fundamental metabolic pathways and emerging antiviral immunity research. This article uniquely integrates biochemical detail with evolutionary insights, showcasing APExBIO’s high-purity Biotin as a cornerstone for advanced assay development.

• DiR (DiIC 18 (7)) in EV Tracking: Protocols & Innovation

  2026-07-29

  Harness the unique near-infrared properties of DiR (DiIC 18 (7)) for high-sensitivity, long-term extracellular vesicle tracking and membrane imaging. This guide delivers actionable workflows, troubleshooting strategies, and key insights from recent advances in EV therapy. Discover how APExBIO’s membrane probe optimizes experimental design for both foundational and translational research contexts.

17110 records 1/1141 page Next 12345 下5页 Last page